MAPK8 and amyotrophic lateral sclerosis: Knowing the identity of those molecules upstream or downstream JNK that are dysregulated in ALS phenotypes may provide biochemical markers to enable earlier diagnosis of the pathology and molecular targets for developing new therapeutic compounds.